PGIUX | VCRCX | PGIUX / VCRCX | |
Total Expense Ratio | 0.98 | 2.08 | 47% |
Annual Report Gross Expense Ratio | 0.98 | 2.10 | 47% |
Fund Existence | 17 years | 7 years | - |
Gain YTD | 12.069 | 11.445 | 105% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 1000 | 10,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 154M | 1.31B | 12% |
Annual Yield % from dividends | 2.08 | 1.00 | 208% |
Returns for 1 year | 5.66 | 8.19 | 69% |
Returns for 3 years | 4.06 | 17.15 | 24% |
Returns for 5 years | 15.89 | 37.18 | 43% |
Returns for 10 years | 32.59 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LYFAX | 13.30 | 0.22 | +1.68% |
AlphaCentric Life Sciences & Hlthcare A | |||
CLARX | 8.19 | 0.06 | +0.74% |
NYLI CBRE Real Estate Class A | |||
BGATX | 18.62 | N/A | N/A |
Baillie Gifford Global Alpha Equities 2 | |||
SVALX | 6.46 | N/A | N/A |
Federated Hermes Strategic Value Div R6 | |||
NSRIX | 25.51 | -0.08 | -0.31% |
Northern World Selection Index I |